Endo International Plc (ENDP)

8.66
0.22 2.60
NASDAQ : Health Technology
Prev Close 8.44
Open 8.47
Day Low/High 8.44 / 8.65
52 Wk Low/High 5.27 / 18.50
Volume 105.71K
Avg Volume 3.51M
Exchange NASDAQ
Shares Outstanding 224.40M
Market Cap 1.92B
EPS -4.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Endo International Plc Announces Debt Refinancing Transactions, Including Cash Tender Offers And Consent Solicitations For Up To $1.0 Billion Aggregate Purchase Price Of Its Outstanding Senior Notes

Endo International Plc Announces Debt Refinancing Transactions, Including Cash Tender Offers And Consent Solicitations For Up To $1.0 Billion Aggregate Purchase Price Of Its Outstanding Senior Notes

DUBLIN, March 14, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced a series of debt refinancing transactions that are intended to help manage the debt maturity profile of it and certain of its subsidiaries (collectively, the...

Endo International Plc Announces Proposed Private Offering Of Senior Secured Notes

Endo International Plc Announces Proposed Private Offering Of Senior Secured Notes

DUBLIN, March 14, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that Par Pharmaceutical, Inc.

Endo To Participate At Cowen & Company 39th Annual Healthcare Conference

Endo To Participate At Cowen & Company 39th Annual Healthcare Conference

DUBLIN, March 4, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Cowen & Company 39 th Annual Healthcare Conference in Boston, Massachusetts on Monday, March...

Endo Announces FDA Decision Not To Include Vasopressin On 503B Bulks List

Endo Announces FDA Decision Not To Include Vasopressin On 503B Bulks List

DUBLIN, March 1, 2019 /PRNewswire/ --  Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.

Endo Will Showcase Late-Breaking Phase 3 CCH Data At The 2019 American Academy Of Dermatology Annual Meeting

Endo Will Showcase Late-Breaking Phase 3 CCH Data At The 2019 American Academy Of Dermatology Annual Meeting

Endo To Present Data From Two Abstracts on Collagenase Clostridium Histolyticum DUBLIN, March 1, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it will present new data showing collagenase clostridium histolyticum (CCH)...

Endo Reports Fourth-Quarter And Full Year 2018 Financial Results

Endo Reports Fourth-Quarter And Full Year 2018 Financial Results

DUBLIN, Feb. 28, 2019 /PRNewswire/ -- Fourth-quarter 2018 revenues increased 2 percent to $786 million Fourth-quarter 2018 Sterile Injectables revenues increased 32 percent to $259 million Fourth-quarter 2018 XIAFLEX ® franchise revenues increased 30...

Endo Announces Termination Of Acquisition Agreements With Somerset Therapeutics And Business Of Affiliate Wintac Limited

Endo Announces Termination Of Acquisition Agreements With Somerset Therapeutics And Business Of Affiliate Wintac Limited

DUBLIN, Feb. 27, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Endo Ventures Limited, Par Pharmaceutical, Inc.

3 Small Biotechs to Watch as Earnings Season Winds Down

3 Small Biotechs to Watch as Earnings Season Winds Down

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

ENDP March 29th Options Begin Trading

ENDP March 29th Options Begin Trading

Investors in Endo International plc saw new options begin trading today, for the March 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new March 29th contracts and identified one put and one call contract of particular interest.

Endo Agrees Not To Oppose Additional Stay Of FDA Litigation Following Restoration Of Government Appropriations

Endo Agrees Not To Oppose Additional Stay Of FDA Litigation Following Restoration Of Government Appropriations

DUBLIN, Feb. 7, 2019 /PRNewswire/ --  Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.

Endo To Announce Fourth-Quarter And Full-Year 2018 Financial Results

Endo To Announce Fourth-Quarter And Full-Year 2018 Financial Results

DUBLIN, Jan. 25, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2018 financial results on February 28, 2019 and members of its senior management team will host a conference call and webcast at...

Endo Announces Anticipated Further Stay Of Compounding Litigation Due To Lapse Of Government Appropriations

Endo Announces Anticipated Further Stay Of Compounding Litigation Due To Lapse Of Government Appropriations

DUBLIN, Dec. 31, 2018 /PRNewswire/ --  Endo International plc ("Endo"; NASDAQ: ENDP) today announced that, due to the ongoing federal government shutdown, the U.

Endo To Participate At J.P. Morgan Healthcare Conference

Endo To Participate At J.P. Morgan Healthcare Conference

DUBLIN, Dec. 19, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.

Endo To Participate At Bank Of America Merrill Lynch Leveraged Finance Conference

Endo To Participate At Bank Of America Merrill Lynch Leveraged Finance Conference

DUBLIN, Nov. 28, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leveraged Finance Conference in Boca Raton, Florida on Tuesday,...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BKE, CEL, INOD, INTX, MDP Downgrades: ATTO, BPI, CPE, ENDP, NP Initiations: BGNE Read on to get TheStreet Quant Ratings' detailed report:

Endo To Participate At Piper Jaffray Global Healthcare Conference

Endo To Participate At Piper Jaffray Global Healthcare Conference

DUBLIN, Nov. 26, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Piper Jaffray Global Healthcare Conference in New York City on Tuesday, November 27, 2018 at...

First Week Of ENDP July 2019 Options Trading

First Week Of ENDP July 2019 Options Trading

Investors in Endo International plc saw new options become available this week, for the July 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

3 Small Biotechs That Came Up Big on Thursday

3 Small Biotechs That Came Up Big on Thursday

Portola Pharmaceuticals, Flexion Therapeutics and BioDelivery Sciences delivered nice third-quarter numbers.

Endo Reports Third-Quarter 2018 Financial Results

Endo Reports Third-Quarter 2018 Financial Results

DUBLIN, Nov. 8, 2018 /PRNewswire/ --  Third-quarter 2018 revenues of $745 million compared to third-quarter 2017 revenues of $787 million Third-quarter 2018 XIAFLEX ® franchise revenues increased 22 percent versus third-quarter 2017 to $64 million...

Endo Announces Positive Results From Phase 3 Studies Of Collagenase Clostridium Histolyticum (CCH) In Patients With Cellulite

Endo Announces Positive Results From Phase 3 Studies Of Collagenase Clostridium Histolyticum (CCH) In Patients With Cellulite

Both RELEASE-1 and RELEASE-2 Studies Demonstrated Highly Statistically Significant Results (P=0.

Tech Doesn't Have Good Defense: Cramer's 'Mad Money' Recap (Thursday 9/6/18)

Tech Doesn't Have Good Defense: Cramer's 'Mad Money' Recap (Thursday 9/6/18)

Jim Cramer, celebrating the opening of the NFL season, says this is just another day of total tech mayhem.

United Parcel Service, TJX Companies: 'Mad Money' Lightning Round

United Parcel Service, TJX Companies: 'Mad Money' Lightning Round

Jim Cramer takes a look at United Parcel Service, TJX Companies, Anheuser-Busch InBev, Fiat Chrysler, AbbVie, Nvidia, Excelixis, Bank of America, Endo Pharmaceutical and more.

Endo Presents Data On The Perception And Measurement Of Cellulite Severity At The American Society For Dermatologic Surgery (ASDS) Annual Meeting

Endo Presents Data On The Perception And Measurement Of Cellulite Severity At The American Society For Dermatologic Surgery (ASDS) Annual Meeting

DUBLIN, Oct. 11, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that data regarding the evaluation and rating of cellulite severity will be presented at the Annual Meeting of the American Society for Dermatologic Surgery (ASDS)...

Endo To Announce Third-Quarter 2018 Financial Results

Endo To Announce Third-Quarter 2018 Financial Results

DUBLIN, Sept. 28, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its third-quarter 2018 financial results on November 8, 2018 and members of its senior management team will host a conference call and webcast at 8:00 a.

Endo Pharmaceuticals Issues Voluntary Nationwide Recall For Two Lots Of Robaxin® 750mg Tablets 100 Count Bottle Packs Due To Incorrect Daily Dosing Information On Label

Endo Pharmaceuticals Issues Voluntary Nationwide Recall For Two Lots Of Robaxin® 750mg Tablets 100 Count Bottle Packs Due To Incorrect Daily Dosing Information On Label

DUBLIN, Sept. 28, 2018 /PRNewswire/ --  Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc.

Endo Agrees To Additional Stay Of FDA Litigation Following FDA's Commitment To Use Best Efforts To Finalize Vasopressin Clinical Need Determination By Year End

Endo Agrees To Additional Stay Of FDA Litigation Following FDA's Commitment To Use Best Efforts To Finalize Vasopressin Clinical Need Determination By Year End

DUBLIN, Sept. 24, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it has agreed to an additional stay of its litigation against the U.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGN, DSS, ENDP, ICUI, PIH, SPB, SPPI, WAAS, YRD Downgrades: BMA, BRT, ELSE, FRBK, HAE, HSKA, JD, MATW, TCMD, TSG Initiations: ALT, TRTX Read on to get TheStreet Quant Ratings' detailed report:

First Week Of September 21st Options Trading For Endo International (ENDP)

First Week Of September 21st Options Trading For Endo International (ENDP)

Investors in Endo International plc saw new options begin trading this week, for the September 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new September 21st contracts and identified one put and one call contract of particular interest.

TheStreet Quant Rating: D+ (Sell)